Aortic coarctation medical therapy

Aortic coarctation Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Aortic Coarctation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
Chest X-Ray
CT
MRI
Angiography
Echocardiography
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Aortic coarctation medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Aortic coarctation medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Aortic coarctation medical therapy
CDC on Aortic coarctation medical therapy
Aortic coarctation medical therapy in the news
Blogs on Aortic coarctation medical therapy
Directions to Hospitals Treating Aortic coarctation
Risk calculators and risk factors for Aortic coarctation medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S.[2], Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S.[4]

Overview

The treatment choice depends on the patients age of presentation, severity, the location of the coarctation and other associated anomalies. For children who present early, the role of medical management is for stablizing the patient for surgery. However, in older kids and adolescent presenting with hypertension treatment is guided towards correction of hypertension and other associated anomalies.

Medical therapy

Early presentation

Treatment in patients with early presentation of coarctation of aorta is supportive, symptomatic and the aim is to stabilize the patient for surgical procedure or catheter intervention.

• Ventilatory support in patients with respiratory distress
• Congestive heart failure - Diuretics, Ionotropes
• Hypotension - Ionotropes
• PgE1 (prostaglandin E1) - Given to keep the ductus arteriosus patent.
• In patients with other associated cardiac defects if the coarctation has a significantly adverse effect on the clinical status, the coarctation should be initially relieved with surgery or balloon angioplasty and the patient reassessed with regard to need for intervention for the associated defects.

Late presentation

Late presenters usually have hypertension. Beta blocker is the treatment of choice for hypertension in these patients both pre and post operatively.

Preoperative

• Beta blockers are the treatment of choice.
• Caution should be taken as too much control of hypertension in upper limb can cause hypotension in lower limbs.
• Surgical treatment of the lesion should not be delayed for the correction of hypertension.